Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.55 - $0.82 $267,644 - $399,033
-486,626 Reduced 74.54%
166,197 $117,000
Q1 2023

May 15, 2023

SELL
$0.65 - $1.37 $379,252 - $799,348
-583,466 Reduced 47.19%
652,823 $486,000
Q4 2022

Feb 14, 2023

BUY
$0.6 - $1.41 $333,070 - $782,714
555,117 Added 81.49%
1,236,289 $897,000
Q3 2022

Nov 14, 2022

BUY
$0.94 - $2.56 $95,177 - $259,207
101,253 Added 17.46%
681,172 $661,000
Q2 2022

Aug 15, 2022

BUY
$1.78 - $5.02 $1 Million - $2.82 Million
562,053 Added 3145.94%
579,919 $1.11 Million
Q1 2022

May 16, 2022

SELL
$3.54 - $8.08 $297,037 - $677,984
-83,909 Reduced 82.45%
17,866 $89,000
Q4 2021

Feb 14, 2022

SELL
$5.69 - $7.83 $2.85 Million - $3.92 Million
-500,977 Reduced 83.11%
101,775 $768,000
Q3 2021

Nov 15, 2021

BUY
$7.88 - $14.0 $4.65 Million - $8.25 Million
589,589 Added 4479.14%
602,752 $4.76 Million
Q2 2021

Aug 16, 2021

SELL
$13.81 - $23.25 $205,133 - $345,355
-14,854 Reduced 53.02%
13,163 $183,000
Q1 2021

May 17, 2021

SELL
$17.65 - $24.16 $2.7 Million - $3.7 Million
-153,190 Reduced 84.54%
28,017 $586,000
Q4 2020

Feb 16, 2021

BUY
$12.83 - $17.84 $2.32 Million - $3.23 Million
181,207 New
181,207 $3.01 Million
Q3 2020

Nov 16, 2020

SELL
$11.01 - $18.52 $2.2 Million - $3.7 Million
-199,673 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$11.11 - $24.72 $1.31 Million - $2.91 Million
117,736 Added 143.69%
199,673 $3.32 Million
Q1 2020

May 14, 2020

BUY
$10.74 - $16.32 $9,848 - $14,965
917 Added 1.13%
81,937 $949,000
Q4 2019

Feb 14, 2020

BUY
$12.94 - $20.58 $1.05 Million - $1.67 Million
81,020 New
81,020 $1.2 Million
Q3 2019

Nov 14, 2019

SELL
$10.93 - $17.47 $174,093 - $278,262
-15,928 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$10.0 - $13.03 $1.11 Million - $1.44 Million
-110,728 Reduced 87.42%
15,928 $207,000
Q1 2019

May 14, 2019

BUY
$9.47 - $17.01 $1.2 Million - $2.15 Million
126,656 New
126,656 $1.2 Million

Others Institutions Holding HARP

About Harpoon Therapeutics, Inc.


  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.